Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.

× No keyword cloud information.

17 in total

1. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy.

Authors: K Sieradzki; T Leski; J Dick; L Borio; A Tomasz
Journal: J Clin Microbiol Date: 2003-04 Impact factor: 5.948

2. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

Authors: M Wootton; R A Howe; R Hillman; T R Walsh; P M Bennett; A P MacGowan
Journal: J Antimicrob Chemother Date: 2001-04 Impact factor: 5.790

3. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.

Authors: Ilana Lopes Baratella da Cunha Camargo; Hui-Min Neoh; Longzhu Cui; Keiichi Hiramatsu
Journal: Antimicrob Agents Chemother Date: 2008-09-29 Impact factor: 5.191

4. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.

Authors: Klaudia Kosowska-Shick; Catherine Clark; Glenn A Pankuch; Pamela McGhee; Bonifacio Dewasse; Linda Beachel; Peter C Appelbaum
Journal: Antimicrob Agents Chemother Date: 2009-07-20 Impact factor: 5.191

5. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.

Authors: Satish K Pillai; Christine Wennersten; Lata Venkataraman; George M Eliopoulos; Robert C Moellering; Adolf W Karchmer
Journal: Clin Infect Dis Date: 2009-10-15 Impact factor: 9.079

6. Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate.

Authors: Madhukiran H Murthy; Michael E Olson; Robert W Wickert; Paul D Fey; Ziba Jalali
Journal: J Med Microbiol Date: 2008-08 Impact factor: 2.472

7. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

Authors: Longzhu Cui; Eiji Tominaga; Hui-Min Neoh; Keiichi Hiramatsu
Journal: Antimicrob Agents Chemother Date: 2006-03 Impact factor: 5.191

8. Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus.

Authors: Soo-Jin Yang; Barry N Kreiswirth; George Sakoulas; Michael R Yeaman; Yan Q Xiong; Ayumi Sawa; Arnold S Bayer
Journal: J Infect Dis Date: 2009-12-15 Impact factor: 5.226

9. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia.

Authors: Timothy S Naimi; Daniel Anderson; Carol O'Boyle; David J Boxrud; Susan K Johnson; Fred C Tenover; Ruth Lynfield
Journal: Clin Infect Dis Date: 2003-06-06 Impact factor: 9.079

Review 10. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.

Authors: Richard H Baltz
Journal: Curr Opin Chem Biol Date: 2009-03-19 Impact factor: 8.822

12 in total

Review 1. Mechanisms of drug resistance: daptomycin resistance.

Authors: Truc T Tran; Jose M Munita; Cesar A Arias
Journal: Ann N Y Acad Sci Date: 2015-10-23 Impact factor: 5.691

2. Striking "seesaw effect" between daptomycin nonsusceptibility and beta-lactam susceptibility in Staphylococcus haemolyticus.

Authors: Carla Vignaroli; Caterina Rinaldi; Pietro E Varaldo
Journal: Antimicrob Agents Chemother Date: 2011-05 Impact factor: 5.191

Review 3. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.

Authors: S J van Hal; D L Paterson; I B Gosbell
Journal: Eur J Clin Microbiol Infect Dis Date: 2010-12-30 Impact factor: 3.267

Review 4. A current perspective on daptomycin for the clinical microbiologist.

Authors: Romney M Humphries; Simon Pollett; George Sakoulas
Journal: Clin Microbiol Rev Date: 2013-10 Impact factor: 26.132

5. Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity.

Authors: Molly E Steed; Ashley D Hall; Hossein Salimnia; Glenn W Kaatz; Keith S Kaye; Michael J Rybak
Journal: Infect Dis Ther Date: 2013-11-29

6. Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin.

Authors: Yael Koton; Zafrir Or; Naiel Bisharat
Journal: Infect Dis Rep Date: 2017-05-31

7. Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain.

Authors: Feng-Jui Chen; Tsai-Ling Lauderdale; Chen-Hsiang Lee; Yu-Chieh Hsu; I-Wen Huang; Pei-Chi Hsu; Chung-Shi Yang
Journal: Front Microbiol Date: 2018-05-25 Impact factor: 5.640

Review 8. Recent advances in Staphylococcus aureus infection: focus on vaccine development.

Authors: Shamshul Ansari; Rajesh Kumar Jha; Shyam Kumar Mishra; Birendra Raj Tiwari; Ahmed Morad Asaad
Journal: Infect Drug Resist Date: 2019-05-13 Impact factor: 4.003

9. Decoding Antioxidant and Antibacterial Potentials of Malaysian Green Seaweeds: Caulerpa racemosa and Caulerpa lentillifera.

Authors: Wing-Fai Yap; Vangene Tay; Sie-Hui Tan; Yoon-Yen Yow; Jactty Chew
Journal: Antibiotics (Basel) Date: 2019-09-17

10. Daptomycin Resistant Staphylococcus aureus Clinical Strain With Novel Non-synonymous Mutations in the mprF and vraS Genes: A New Insight Into Daptomycin Resistance.

Authors: Artur J Sabat; Marco Tinelli; Hajo Grundmann; Viktoria Akkerboom; Monica Monaco; Maria Del Grosso; Giulia Errico; Annalisa Pantosti; Alexander W Friedrich
Journal: Front Microbiol Date: 2018-11-06 Impact factor: 5.640